AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+2.38%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$15.8B
AUM Growth
+$903M
(+6%)
Cap. Flow
+$640M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
59.4%
Holding
1,049
New
56
Increased
385
Reduced
332
Closed
59
Top Buys
| 1 |
Hess Midstream
HESM
|
$137M |
| 2 |
Western Midstream Partners
WES
|
$117M |
| 3 |
Plains All American Pipeline
PAA
|
$105M |
| 4 |
Sunoco
SUN
|
$75.6M |
| 5 |
Delek Logistics
DKL
|
$43.6M |
Top Sells
| 1 |
Energy Transfer Partners
ET
|
$66.5M |
| 2 |
Cummins
CMI
|
$27.8M |
| 3 |
Williams Companies
WMB
|
$27.7M |
| 4 |
Gilead Sciences
GILD
|
$26.9M |
| 5 |
Corning
GLW
|
$25.6M |
Sector Composition
| 1 | Energy | 68.67% |
| 2 | Technology | 4.5% |
| 3 | Financials | 3.53% |
| 4 | Consumer Discretionary | 3.3% |
| 5 | Healthcare | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
SIGA Technologies
SIGA
$608M
| $266K | ﹤0.01% |
44,250
-500
| -1% | -$3.01K |
|
952
Tidewater
TDW
$2.83B
| $265K | ﹤0.01% |
4,850
| – | – |
|
953
D.R. Horton
DHI
$52.7B
| $256K | ﹤0.01% |
1,834
| – | – |
|
|
SLRN
954
DELISTED
ACELYRIN
SLRN
| $255K | ﹤0.01% |
81,129
+3,883
| +5% | +$12.2K |
|
955
International Seaways
INSW
$2.27B
| $254K | ﹤0.01% |
7,075
| – | – |
|
956
Green Brick Partners
GRBK
$3.14B
| $253K | ﹤0.01% |
4,473
| – | – |
|
957
Smith Douglas Homes
SDHC
$983M
| $250K | ﹤0.01% |
9,750
-200
| -2% | -$5.13K |
|
958
Aldeyra Therapeutics
ALDX
$332M
| $240K | ﹤0.01% |
48,155
+2,619
| +6% | +$13.1K |
|
959
Ardmore Shipping
ASC
$476M
| $240K | ﹤0.01% |
19,750
-500
| -2% | -$6.08K |
|
960
Rigel Pharmaceuticals
RIGL
$720M
| $240K | ﹤0.01% |
+14,240
| New | +$240K |
|
961
Monolithic Power Systems
MPWR
$40.6B
| $234K | ﹤0.01% |
396
| – | – |
|
962
Dream Finders Homes
DFH
$2.67B
| $234K | ﹤0.01% |
10,064
-200
| -2% | -$4.65K |
|
963
Rezolute
RZLT
$642M
| $230K | ﹤0.01% |
+46,850
| New | +$230K |
|
|
ITOS
964
DELISTED
iTeos Therapeutics
ITOS
| $227K | ﹤0.01% |
29,540
+3,065
| +12% | +$23.5K |
|
|
SLI
965
Standard Lithium
SLI
$586M
| $227K | ﹤0.01% |
155,337
+61,283
| +65% | +$89.5K |
|
966
Vanda Pharmaceuticals
VNDA
$274M
| $226K | ﹤0.01% |
47,149
+3,113
| +7% | +$14.9K |
|
967
Regeneron Pharmaceuticals
REGN
$60.1B
| $221K | ﹤0.01% |
310
| – | – |
|
968
Prologis
PLD
$105B
| $215K | ﹤0.01% |
2,034
-160
| -7% | -$16.9K |
|
969
Amylyx Pharmaceuticals
AMLX
$887M
| $210K | ﹤0.01% |
+55,430
| New | +$210K |
|
|
CMPS
970
Compass Pathways
CMPS
$489M
| $209K | ﹤0.01% |
55,332
+2,927
| +6% | +$11.1K |
|
971
4D Molecular Therapeutics
FDMT
$309M
| $208K | ﹤0.01% |
37,379
-1,964
| -5% | -$10.9K |
|
972
Larimar Therapeutics
LRMR
$331M
| $200K | ﹤0.01% |
+51,590
| New | +$200K |
|
973
Eledon Pharmaceuticals
ELDN
$156M
| $199K | ﹤0.01% |
+48,310
| New | +$199K |
|
974
ProKidney
PROK
$310M
| $175K | ﹤0.01% |
103,477
+6,081
| +6% | +$10.3K |
|
975
Zentalis Pharmaceuticals
ZNTL
$128M
| $174K | ﹤0.01% |
57,587
+1,371
| +2% | +$4.15K |
|